Skip to main content

Female Sterilization
vs
Pill

A side-by-side comparison of two birth control methods — efficacy, cost, how they work, and who shouldn't use them.

Side-by-side comparison

Method
Female Sterilization

Female Sterilization

A permanent surgical procedure that blocks or removes the fallopian tubes to prevent pregnancy.

Pill

Pill

No non-hormonal birth control pill is FDA-approved in the US. Ormeloxifene (centchroman) is approved and used in India.

Efficacy99.5% typical use

Most effective: over 99 out of 100 people successfully prevent pregnancy per year.

Limited evidence see details

Limited evidence: no verifiable efficacy data available.

Cost$0–$6,000

Insurance: Usually

Contact provider

Insurance: Varies

DurationPermanentWeekly pill (ongoing)
ReversibilityPermanentReversible
STI ProtectionNoNo
How it works

Surgical disruption (clipping, banding, cauterization, or complete removal) of the fallopian tubes prevents eggs from reaching the uterus and sperm from reaching the egg.

Ormeloxifene (centchroman) is a selective estrogen receptor modulator (SERM) that prevents pregnancy by inhibiting implantation of a fertilized egg in the endometrium. It does not suppress ovulation and does not contain estrogen or progestin. It is not FDA-approved in the US.

PrescriptionRequired Prescription requiredRequired Prescription required
Available Products2 products1 product
Side effects
  • Surgical risks (bleeding, infection, organ damage)
  • Anesthesia side effects
  • Ectopic pregnancy (small but serious risk if failure occurs)
  • Menstrual irregularities (delayed or altered periods; common, about 8-12% of users)
  • Headache
  • Nausea
  • Abdominal discomfort
  • Breast tenderness
Who shouldn't use this
  • Medical instability for general anesthesia or laparoscopy
  • Uncertainty about future fertility desires
  • Polycystic ovarian disease (PCOS)
  • Recent history of jaundice or hepatic impairment
  • Renal impairment
  • Cervical hyperplasia or chronic cervicitis
  • Pregnancy
  • Hypersensitivity to ormeloxifene